This forum was the second in a two-part series that looks at racial equity in the drug development system, from investment all the way through access. It focused on equity in the patent system, clinical trials, health care delivery, and affordability.
Watch the recording to learn more about the first part of this conversation.
|10:30 - 10:45 a.m.||Opening remarks|
|10:45 - 11:20 a.m.||Fireside chat: Author and ethicist Harriet Washington on racial equity in clinical trials and the patent system|
|11:20 - 11:55 a.m.||Fireside chat: Dr. Foluso Fakorede on racial equity in health care delivery and drug affordability|
|11:55 - 12:00 p.m.||Closing remarks|
Ronald L. Copeland, MD, FACS
Ronald Copeland, MD, FACS, is senior vice president of National Equity, Inclusion, and Diversity strategy and policy and chief equity, inclusion, and diversity officer for Kaiser Permanente. Through multiple collaborations, he leads Kaiser Permanente’s program-wide efforts to ensure our strategic vision for equity, inclusion, and diversity is successfully implemented to drive strategic business and mission outcomes, empower communities we serve, and result in all Kaiser Permanente members achieving health and health care outcomes that are high quality, equitable, and increasingly more affordable. Dr. Copeland is a board member of Kaiser Permanente School of Medicine, the National Organization on Disability, and the Center for Healthcare Innovation.
Foluso Fakorede, MD
Dr. Foluso Fakorede, physician, entrepreneur and advocate for health care injustice, spent his formative years in Nigeria and immigrated to America as a teenager. He obtained a bachelor’s degree in biology with a minor in economics from Rutgers University. Then he received his medical degree from UMDNJ-Robert Wood Johnson Medical School in Camden, New Jersey. He completed internship and residency in internal medicine at New York Presbyterian Weill Cornell Hospital. Dr. Fakorede returned to New Jersey to complete fellowship in cardiology, interventional cardiology, and endovascular intervention at Cooper University Hospital-Camden, New Jersey. During his fellowship, Dr. Fakorede was honored with the distinction of Chief Cardiology Fellow. Dr. Fakorede specializes in preventative cardiovascular management, women’s heart health and catheter-based procedural focus in coronary atherosclerosis disease (CAD) and peripheral atherosclerosis disease (PAD). He currently serves on the Society of Cardiac Angiography and Intervention (SCAI) vascular disease committee.
Harriet A. Washington
Harriet A. Washington is a proliﬁc science writer, editor, and ethicist who has authored six well-received books, including the seminal Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present, which won a National Book Critics Circle Award, the PEN/Oakland Award, and the American Library Association Black Caucus Nonﬁction Award.
Washington is a writing fellow in bioethics at Harvard Medical School, a fellow of the New York Academy of Medicine, and was the 2015-2016 Miriam Shearing Fellow at the University of Nevada’s Black Mountain Institute. She has also been a research fellow in medical ethics at Harvard Medical School, a visiting fellow at the Harvard TH Chan School of Public Health, a visiting scholar at DePaul University College of Law and a senior research scholar at the National Center for Bioethics at Tuskegee University. She has held fellowships at Stanford University and teaches bioethics at Columbia University, where she delivered the 2020 commencement speech to Columbia’s School of Public Health graduates and won Columbia’s 2020 Mailman School Of Public Health’s Public Health Leadership Award, as well as its 2020-21 Kenneth and Mamie Clark Distinguished Lecture Award.